In this meta-analysis of randomized controlled trials in participants with rheumatoid arthritis, N-acetylcysteine (in addition to rheumatoid arthritis medications) improved some disease symptoms and reduced inflammation, but the results should be interpreted with caution.
This Study Summary was published on December 27, 2024.
